Volume 29-30

Paper Collection (in Progress)
Resistance and Therapy Failure in Eye cancer



PD Dr. Vinodh Kakkassery & Prof. Dr. med. Ludwig Heindl (Editors)

Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab

Kakkassery V., Heindl L., Rokohl A., Chronopoulos A., Schutz J., Ranjbar M., Schargus M., Böker A., Winterhalter S., Stübiger N.

Neurosignals 2021;29(S1):1-7

HTML PDF https://doi.org/10.33594/000000367


Interventional Radiotherapy (Brachytherapy) in Eyelid and Ocular Surface Tumors: A Review for Treatment of Naïve and Recurrent Malignancies

Pagliara M., Kakkassery V., Fionda B., Lepore D., Kovács G., Tagliaferri L., Blasi M.

Neurosignals 2022;30(S1):1-10

HTML PDF https://doi.org/10.33594/000000505


Therapy Resistance and Failure in Uveal Melanoma

Li S., Guo Y., Wawer Matos P., Rokohl A., Heindl L.

Neurosignals 2022;30(S1):11-20

HTML PDF https://doi.org/10.33594/000000555


Therapy Failure and Resistance Mechanismin Eyelid and Ocular Surface Tumors

Ju X., Gaca P., Fan W., Rokohl A., Guo Y., Wawer Matos P., Emmert S., Kakkassery V., Heindl L.

Neurosignals 2022;30(S1):21-38

HTML PDF https://doi.org/10.33594/000000560


A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma

Chronopoulos A., Babst N., Schiemenz C., Schutz J., Heindl L., Ranjbar M., Kakkassery V.

Neurosignals 2022;30(S1):39-58

HTML PDF https://doi.org/10.33594/000000585